Evaluation of immunohistochemical markers of p16 and p53 in patients with pathological diagnoses of actinic keratosis, Bowen’s disease, and seborrheic keratosis; a cross-sectional study from Alzahra hospital, Isfahan, Iran (2018-2022)

Introduction: While Bowen’s disease (BD) and actinic keratosis (AK) are premalignant conditions, seborrheic keratosis (SK) is a benign lesion; therefore, the differentiation of these processes is of clinical importance. Objectives: This study aimed to assess the P16 and P53 markers expression in patients with pathological diagnoses of AK, BD, and SK. Materials and Methods: This cross-sectional study included all patients with the final pathological diagnosis of AK, SK, and BD between 2018 and 2022 in Al-Zahra hospital, Isfahan, Iran. Immunohistochemical staining using the EnVision method was done for all samples. The positive results of the P16 marker were interpreted as the block staining of the nucleus and cytoplasm, and in the case of the P53 marker, the positive results were interpreted as the block staining of the nucleus. Finally, we investigated and compared the expression pattern of P53 and P16 markers in three groups of BDs, SK, and AK. Results: The expression patterns of p16 and p53 varied notably among patients with AK, SK, and BD. In cases of AK and SK, p16 predominantly exhibited null or mosaic patterns, while BD was characterized by a block pattern. For p53, both AK and BD were more likely to display null or strong patterns, whereas SK was more frequently associated with a mosaic pattern. The diagnostic value of these markers indicated that p53 and p16 patterns could effectively assist in distinguishing BD from SK and AK. Conclusion: The distinct expression patterns of p16 and p53 in AK, SK, and BD underscore their potential as valuable diagnostic biomarkers. The differences in p16 and p53 patterns can aid in accurately differentiating between benign and precancerous lesions, supporting their incorporation into diagnostic protocols to improve patient management and treatment outcomes.

Authors

Institutions

Publication Details

Journal
Immunopathologia Persa
Published
2024-09-04
DOI
https://doi.org/10.34172/ipp.2024.43745
Primary Topic
Nonmelanoma Skin Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of immunohistochemical markers of p16 and p53 in patients with pathological diagnoses of actinic keratosis, Bowen’s disease, and seborrheic keratosis; a cross-sectional study from Alzahra hospital, Isfahan, Iran (2018-2022)

Pegah Hedayat, Parto Nasri, Shahnaz Eskandari, Maryam Derakhshan et al.
Immunopathologia Persa
Nonmelanoma Skin Cancer Studies
article

Evaluation of immunohistochemical markers of p16 and p53 in patients with pathological diagnoses of actinic keratosis, Bowen’s disease, and seborrheic keratosis; a cross-sectional study from Alzahra hospital, Isfahan, Iran (2018-2022)

Pegah Hedayat, Parto Nasri, Shahnaz Eskandari, Maryam Derakhshan, Narges Motamedi, Arman Goudarzi Nezhad, Marzieh Derakhshan
article en

Abstract

Introduction: While Bowen’s disease (BD) and actinic keratosis (AK) are premalignant conditions, seborrheic keratosis (SK) is a benign lesion; therefore, the differentiation of these processes is of clinical importance. Objectives: This study aimed to assess the P16 and P53 markers expression in patients with pathological diagnoses of AK, BD, and SK. Materials and Methods: This cross-sectional study included all patients with the final pathological diagnosis of AK, SK, and BD between 2018 and 2022 in Al-Zahra hospital, Isfahan, Iran. Immunohistochemical staining using the EnVision method was done for all samples. The positive results of the P16 marker were interpreted as the block staining of the nucleus and cytoplasm, and in the case of the P53 marker, the positive results were interpreted as the block staining of the nucleus. Finally, we investigated and compared the expression pattern of P53 and P16 markers in three groups of BDs, SK, and AK. Results: The expression patterns of p16 and p53 varied notably among patients with AK, SK, and BD. In cases of AK and SK, p16 predominantly exhibited null or mosaic patterns, while BD was characterized by a block pattern. For p53, both AK and BD were more likely to display null or strong patterns, whereas SK was more frequently associated with a mosaic pattern. The diagnostic value of these markers indicated that p53 and p16 patterns could effectively assist in distinguishing BD from SK and AK. Conclusion: The distinct expression patterns of p16 and p53 in AK, SK, and BD underscore their potential as valuable diagnostic biomarkers. The differences in p16 and p53 patterns can aid in accurately differentiating between benign and precancerous lesions, supporting their incorporation into diagnostic protocols to improve patient management and treatment outcomes.

Immunopathologia Persa
Isfahan University of Medical Sciences (IR)
Isfahan University of Medical Sciences
Openalex Percentile: Top 62%
Nonmelanoma Skin Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.